Surgical Dressing Market Size & Share 2023 to 2032

Surgical Dressing Market Size

Surgical Dressing Market was valued at USD 6 billion in 2022 and is estimated to account for USD 10.7 billion by 2032. Surgical dressing is a sterile material used to protect and aid the healing of wounds, surgical incisions, or injuries. The increasing global population base, coupled with advances in medical technology, has led to a significant rise in the number of surgical procedures.

For instance, according to the American Society of Plastic Surgeons, there was a 19% increase in cosmetic surgeries in 2022. Body-focused procedures, including liposuction, tummy tucks, and lifts, accounted for a 25% growth, totaling 576,485 procedures in 2022. Therefore, the demand for surgical dressings has consequently increased in tandem with the growing number of surgeries, ranging from routine procedures to complex surgeries.
 

Furthermore, advances in medical technology have led to the development of more sophisticated and effective surgical dressings. These advancements include the use of antimicrobial dressings, specialized wound dressings, and moist wound dressing, which is estimated to account USD 7.2 billion by 2032. Thus, these innovations improve patient comfort, accelerate wound healing, and reduce the risk of complications.
 

COVID-19 Impact

The COVID-19 pandemic negatively affected the surgical dressing market through disrupted supply chains, reduced demand from postponed elective surgeries, and resource redirection to COVID-19 care. Patient reluctance to seek care and increased infection control measures added to the challenges. Financial strain on healthcare providers further impacted resource allocation. Thus, the pandemic resulted in disruption, changed patient behaviour, and presented resource allocation challenges that adversely impacted the market progress.
 

Surgical Dressing Market Trends

The prevalence of chronic diseases such as diabetes, cardiovascular diseases, and obesity is on the rise worldwide. For instance, the United Nations (UN) has predicted that by 2050, chronic diseases such as cardiovascular diseases, cancer, diabetes, and respiratory illnesses will account for 86% of the 90 million deaths that occur annually. Thus, these conditions often result in non-healing wounds, ulcers, and the need for surgical interventions. Therefore, surgical dressings are vital in managing and treating chronic wounds, and as chronic disease rate increase, so does the demand for advanced wound care products.
 

• Furthermore, with greater access to healthcare information, patients and healthcare professionals are increasingly aware of the importance of wound care biologics. Proper wound management is essential for preventing complications, reducing hospital stays, and improving overall patient outcomes.
   
• Hence, this increased awareness has emphasized the importance of utilizing high-quality surgical dressings for wound treatment, consequently driving market expansion.
   

Surgical Dressing Market Analysis

The market by product is categorized into primary dressing, secondary dressing, and other products. The primary dressing segment is bifurcated into foam dressing, alginate dressing, soft silicone dressing, composite dressing, hydrogel dressing, hydrocolloid dressing and film dressing. This segment garnered USD 2.9 billion revenue size in the year 2022.
 

• The dominance of the primary dressing segment can be attributed to its essential role in wound management, versatility across various wound types, continuous innovation, clinical preference, patient comfort, and the increasing demand for high-quality wound care solutions.
   
• Therefore, these factors collectively contribute to its strong market presence and continued growth.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the surgical dressing market is segmented into diabetes-based surgeries, cardiovascular diseases, ulcers, burns, transplant sites, and other applications. The diabetes-based surgeries segment accounted for over 27% business share in the year 2022.
 

• High segment growth is attributed due to the increasing prevalence of diabetes-related surgical procedures, notably amputations and diabetic foot ulcer interventions. For instance, the National Institute of Health reports an annual global occurrence of diabetic foot ulcers ranging from 9.1 to 26.1 million cases.
   
• Thus, specialized surgical dressings are in high demand for managing chronic wounds such as foot ulcers, preventing infections, and maintaining a sterile environment.
   

The surgical dressing market by end-use is categorized into hospital, specialty clinics, home healthcare, ambulatory surgery centers, and other end-users. The hospitals garnered USD 2.7 billion revenue size in the year 2022.

• Hospitals are high-traffic hubs for surgeries, wound care, and post-operative recovery, leading to a consistent demand for surgical dressings. Their advanced medical resources enable a wide range of surgical applications, emphasizing specialized dressing requirements.
   
• Furthermore, hospitals also play a pivotal role in chronic disease management, requiring wound care.
   

Thus, emergency services, quality standards adherence, research and development, and comprehensive wound care programs further fuel the demand for surgical dressings in hospitals, cementing their leading position in the market.
 

U.S. surgical dressing market accounted for USD 2.2 billion revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
 

• The U.S. has taken a commanding position in the market, primarily due to its advanced healthcare infrastructure, high surgical procedural volume, coupled with prevalence of chronic diseases.
   
• The country's strict quality standards and focus on medical research and innovation ensure the use of high-quality surgical dressings. Furthermore, robust emergency healthcare services and the demand for specialized dressings also contribute to its market leadership, propelling growth and making the U.S. a dominant player in the global market.
   

Surgical Dressing Market Share

The surgical dressing industry is consolidated, with key players including Smith & Nephew, Johnson & Johnson, and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares. For instance, in October 2021, Healthium Medtech Limited expanded its range of patented wound care and infection prevention products with the introduction of TRUSHIELD NXT surgical wound dressing.

Some of the eminent market participants operating in the surgical dressing industry include:

• 3M Company
• Advancis Medical
• Cardinal Health
• Smith & Nephew
• Johnson & Johnson Private Limited
• ConvaTec Group PLC
• Mölnlycke Health Care AB
• Derma Sciences Inc. (Integra LifeSciences)
• Baxter International Inc.
• Coloplast Corp
• Medline Industries
• Medtronic plc
• Healthium Medtech

Surgical Dressing Industry News:

• In April 2023, the FDA clearance for 3M Health Care's 3M Veraflo Therapy, including 3M V.A.C. Veraflo Cleanse Choice Dressing, and 3M Veraflo Cleanse Choice Complete Dressing expanded the company's customer base and increased its revenue. This innovative approach for wound care offered improved treatment options, making it more attractive to healthcare providers and potentially boosting the company's financial performance.
   
• In September 2021, Healthium Medtech acquired CareNow Medical Private Limited. This strategic move aimed at enhancing company’s product portfolio by adding patented and unique offerings in the field of advanced wound management and infection prevention.
   

Surgical dressing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and volume in Units from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product, 2018 – 2032 (USD Million and Units)

• Primary dressing 
• Foam dressing
• Alginate dressing
• Soft silicone dressing
• Composite dressing
• Hydrogel dressing
• Hydrocolloid dressing
• Film dressin 
• Secondary dressing
• Absorbents
• Bandages
• Adhesive tapes
• Protectives 
• Other products

By Application, 2018 – 2032 (USD Million)

• Diabetes based surgeries
• Cardiovascular diseases
• Ulcers
• Burns
• Transplant sites
• Other applications

By End-use, 2018 – 2032 (USD Million)

• Hospital
• Specialty clinics
• Home healthcare
• Ambulatory surgery centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa